Richard Gregory 4
4 · Interpace Diagnostics Group, Inc. · Filed Dec 6, 2018
Insider Transaction Report
Form 4
Richard Gregory
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2018-12-05+67,000→ 67,000 totalExercise: $1.08Exp: 2028-12-05→ Common Stock (67,000 underlying)
Holdings
- 31,241
Common Stock
Footnotes (1)
- [F1]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.